PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1608712
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1608712
Veterinary Antibiotics Market, By Drug Type, By Dosage Form, By Animal Type, By Geography
Veterinary antibiotics market is estimated to be valued at USD 4.02 Bn in 2024 and is expected to reach USD 5.23 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 3.8% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | 4.02 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 3.80% | 2031 Value Projection: | 5.23 Bn |
Veterinary antibiotics market has witnessed significant growth due to rising animal healthcare expenditure and increasing prevalence of zoonotic diseases. Growing animal adoption, particularly in developed regions, has also boosted demand for antibiotics to prevent and treat various infections in companion animals. Moreover, changing lifestyles and increasing focus on protein-rich diets from animal sources have revved up meat production across the globe. Large scale livestock production practices necessitate the proper use of antibiotics to promote growth and prevent diseases in animals reared for meat consumption.
Market Dynamics
Rising consumption of livestock-derived food products can drive the veterinary antibiotics market growth. In 2019, according to the United Nations Food and Agriculture Organization, global meat production is projected to grow approximately 15% in the period between 2020 and 2030. However, overuse and misuse of antibiotics in the livestock sector has led to antibiotic resistance, thus, hampering the market growth. Alternative treatment options including bacteriophages and probiotics present significant opportunities for market players. Growing veterinary healthcare infrastructure in developing nations can create new avenues for antibiotics manufacturers in the near future.
Key features of the study
This report provides in-depth analysis of the global veterinary antibiotics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global veterinary antibiotics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck & Co., Inc., Ceva Sante Animale, Zoetis, Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals, Elanco Animal Health Incorporated, Virbac S.A., Bimeda, Inc., Vetoquinol, Zydus Animal Health, Blacksmith Medicines, Inovet, Calier, and Phibro Animal Health Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global veterinary antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary antibiotics market
Market Segmentation
- By Drug Type Insights (Revenue, USD Bn, 2019 - 2031)
- Aminoglycosides
- B-Lactam Antibiotics
- Chloramphenicol
- Fluoroquinolones
- Glycopeptides
- Lincosamides
- Macrolides
- Polymixins
- Tetracyclines
- Others
- By Dosage Form Insights (Revenue, USD Bn, 2019 - 2031)
- Powder
- Solutions
- Injections
- Others
- By Animal Type Insights (Revenue, USD Bn, 2019 - 2031)
- Companion
- Canine
- Feline
- Livestock
- Bovine
- Ovine
- Porcine
- Others (Poultry, etc.)
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Merck & Co., Inc.
- Ceva Sante Animale
- Zoetis
- Boehringer Ingelheim International GmbH
- Dechra Pharmaceuticals
- Elanco Animal Health Incorporated
- Virbac S.A.
- Bimeda, Inc.
- Vetoquinol
- Zydus Animal Health
- Blacksmith Medicines
- Inovet
- Calier
- Phibro Animal Health Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Veterinary Antibiotics Market, By Drug Type
- Veterinary Antibiotics Market, By Dosage Form
- Veterinary Antibiotics Market, By Animal Type
- Veterinary Antibiotics Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Epidemiology
4. Veterinary Antibiotics Market, By Drug Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Aminoglycosides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- B-Lactam Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Chloramphenicol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Fluoroquinolones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Glycopeptides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Lincosamides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Macrolides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Polymixins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Tetracyclines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Veterinary Antibiotics Market, By Dosage Form, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Veterinary Antibiotics Market, By Animal Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Companion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Canine
- Feline
- Livestock
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Bovine
- Ovine
- Porcine
- Others (Poultry, etc.)
7. Veterinary Antibiotics Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Animal Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ceva Sante Animale
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zoetis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dechra Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elanco Animal Health Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Virbac S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bimeda, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vetoquinol
- Zydus Animal Health
- Blacksmith Medicines
- Inovet
- Calier
- Phibro Animal Health Corporation
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
